What is the Impact Factor of Oncology Research?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Oncology Research is 4.60, ranking in quartile Q2 of Web of Science (SCIE).

Is Oncology Research indexed in Web of Science or Scopus?

Yes, Oncology Research is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.102 (Q1) and an H-index of 79.

Who publishes Oncology Research and what is the Article Processing Charge (APC)?

Oncology Research is published by Cognizant Communication Corporation. The estimated Article Processing Charge (APC) is approximately $3,195 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Oncology Research?

The official ISO-4 abbreviation of Oncology Research is "ONCOL RES". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #4,167Hybrid

Oncology Research

Abbreviation (ISO):ONCOL RES

•

Identifier (ISSN):0965-0407(Print)/1555-3906(Online)

•

Publisher:Cognizant Communication Corporation

Official Website Submission Portal Compare

Clarivate IF (2026)

4.6↑ +0.5

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Oncology Research

WoS Q2

Annual Impact Factor Metric

Current (2026):4.6

Scopus SJR & RankScopus Q1

1.102

#4,167

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

79 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

27articles/year

57.05% Gold OA•95.83% Original Research

Aims & Scope

Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.

Topics Covered (Recognized by AI)

Biology96.4%Genetics95.7%Medicine94.2%Chemistry91.4%Biochemistry90%Internal medicine85.4%Cancer research66.3%Gene65.3%Cancer61.7%Cell culture48.9%Apoptosis42.1%Cell biology37.4%Pathology35.5%In vitro33.4%Cell growth33.2%Cell33.1%Immunology31.4%Molecular biology27.9%Organic chemistry26.2%Surgery25.5%Downregulation and upregulation23.5%Endocrinology21.4%Physics20.3%

Primary Research Areas

Medicine Oncology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ONCOLOGY

Rank101/333

IndexSCIE

JCISCIE2026

ONCOLOGY

Rank80/333

IndexSCIE

Category	Index	Rank	Quartile
ONCOLOGY	JCRSCIE	101/333	Q2
ONCOLOGY	JCISCIE	80/333	Q1

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF4.6

Articles / Year276

Total Citations56

2025

IF4.1

Articles / Year251

Total Citations519

2024

IF2

Articles / Year225

Total Citations1,205

2023

IF3.1

Articles / Year105

Total Citations1,389

2022

IF4.938

Articles / Year34

Total Citations402

Year	Impact Factor	Articles / Year	Total Citations
2026	4.6	276	56
2025	4.1	251	519
2024	2	225	1,205
2023	3.1	105	1,389
2022	4.938	34	402
2021	5.574	61	609
2020	4.949	43	786
2019	4.634	68	1,884
2018	3.143	128	4,056
2017	—	246	8,283
2016	—	145	4,337
2015	—	32	645

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,167Scopus Q1SCImago Profile

Scopus Coverage:1992-2000, 2002-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicine

Scopus Citation Rank (SJR)Q1

1.102

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

4.69

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,195 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,085

3-Year Documents232

Citable Documents230

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q1

Cancer ResearchQ2

OncologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

2区ONCOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

In warning list

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Oncology Research (abbr: ONCOL RES, ISSN: 0965-0407) is a peer-reviewed international scholarly journal in the field of Medicine, published by Cognizant Communication Corporation in United States since 1992. The periodical holds a Journal Impact Factor (JIF) of 4.60, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.102 (Q1), an H-index of 79.

The journal enforces rigorous peer evaluation with a publication frequency of Monthly, an annual output of approximately 27 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,195 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.